Ubiquitin and SUMO conjugation as biomarkers of acute myeloid leukemias response to chemotherapies

Ubiquitin and the ubiquitin-like SUMO are covalently conjugated to thousands of proteins to modulate their function and fate. Many of the enzymes involved in their conjugation are dysregulated in cancers and involved in cancer cell response to therapies. We describe here the identification of biomar...

Descripción completa

Detalles Bibliográficos
Autores principales: Gâtel, Pierre, Brockly, Frédérique, Reynes, Christelle, Pastore, Manuela, Hicheri, Yosr, Cartron, Guillaume, Piechaczyk, Marc, Bossis, Guillaume
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Life Science Alliance LLC 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167290/
https://www.ncbi.nlm.nih.gov/pubmed/32303586
http://dx.doi.org/10.26508/lsa.201900577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7167290/
https://www.ncbi.nlm.nih.gov/pubmed/32303586
http://dx.doi.org/10.26508/lsa.201900577

Ejemplares similares